This issue of Global Biotech Monthly features a special article introducing the global precision medicine industry. In an interview, Leeuwenhoek CEO Associate Professor Xu Chengzhi introduced the relationship between intestinal microorganisms and chronic metabolic diseases, and introduced Leeuwenhoek's unique one-stop service for intestinal bacteria-targeted precision medicine.
Image source: Global Biotech Monthly
Full report:
Original URL: https://news.gbimonthly.com/tw/magazine/article_show.php?num=66243&menu=1461&p_id=122
